ArticleFrontiers in neurology2024

Phosphorylated neurofilament heavy chain in cerebrospinal fluid and plasma as a Nusinersen treatment response marker in childhood-onset SMA individuals from Serbia.

Miloš Brkušanin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.